pharmacy exams
Open in Telegram
Esraa Team for knowledge بوتات الدفعة: @M_V2BOT @MFI_IsrUCOPbot قناة الملازم : https://t.me/PH_doc_21 كروب القناة : https://t.me/+mgZhEcPD6CtlYTNi
Show more2 829
Subscribers
No data24 hours
-97 days
-2730 days
Data loading in progress...
Similar Channels
Tags Cloud
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
September '25
September '250
in 0 channels
August '25
+4
in 0 channels
Get PRO
July '25
+5
in 0 channels
Get PRO
June '25
+6
in 0 channels
Get PRO
May '25
+38
in 1 channels
Get PRO
April '25
+20
in 2 channels
Get PRO
March '25
+35
in 2 channels
Get PRO
February '25
+8
in 1 channels
Get PRO
January '25
+15
in 1 channels
Get PRO
December '24
+27
in 4 channels
Get PRO
November '24
+33
in 2 channels
Get PRO
October '24
+34
in 2 channels
Get PRO
September '24
+29
in 0 channels
Get PRO
August '24
+42
in 0 channels
Get PRO
July '24
+101
in 1 channels
Get PRO
June '24
+137
in 0 channels
Get PRO
May '24
+228
in 9 channels
Get PRO
April '24
+215
in 8 channels
Get PRO
March '24
+206
in 5 channels
Get PRO
February '24
+139
in 2 channels
Get PRO
January '24
+197
in 5 channels
Get PRO
December '23
+231
in 4 channels
Get PRO
November '23
+65
in 4 channels
Get PRO
October '23
+112
in 2 channels
Get PRO
September '23
+96
in 0 channels
Get PRO
August '23
+57
in 0 channels
Get PRO
July '23
+61
in 0 channels
Get PRO
June '23
+130
in 0 channels
Get PRO
May '23
+517
in 0 channels
Get PRO
April '23
+191
in 0 channels
Get PRO
March '23
+98
in 0 channels
Get PRO
February '23
+26
in 0 channels
Get PRO
January '23
+331
in 0 channels
Get PRO
December '22
+141
in 0 channels
Get PRO
November '22
+191
in 0 channels
Get PRO
October '22
+110
in 0 channels
Get PRO
September '22
+10
in 0 channels
Get PRO
August '22
+11
in 0 channels
Get PRO
July '22
+11
in 0 channels
Get PRO
June '22
+46
in 0 channels
Get PRO
May '22
+136
in 0 channels
Get PRO
April '22
+24
in 0 channels
Get PRO
March '22
+480
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 03 September | 0 | |||
| 02 September | 0 | |||
| 01 September | 0 |
Channel Posts
Summer Pharmacy Training
قناة تدريب صيفي مجاني100% لطلاب الصيدلة
مادة علمية مرتبة – ملازم احترافية – شروحات فويز – كيسات تطبيقية – متابعة مستمرة
إذا تحب تجهز نفسك لسوق العمل وتطوّر طريقة تفكيرك وتعاملك المهني،
هاي فرصتك!
انطلاقتنا: 6/15
الرابط: [ https://t.me/SummerPharmacyIQ
| 2 | Summer Pharmacy Training
قناة تدريب صيفي مجاني100% لطلاب الصيدلة
مادة علمية مرتبة – ملازم احترافية – شروحات فويز – كيسات تطبيقية – متابعة مستمرة
إذا تحب تجهز نفسك لسوق العمل وتطوّر طريقة تفكيرك وتعاملك المهني،
هاي فرصتك!
انطلاقتنا: 6/15
الرابط: [ https://t.me/SummerPharmacyIQ | 1 |
| 3 | ( وَأَنَّ سَعْيَهُ سَوْفَ يُرَى ) | 1 297 |
| 4 |  No text... | 1 343 |
| 5 | Drug and its resistance type
P-glycoprotein substrates (general drugs)
• Acquired resistance via decreased accumulation of the drug due to drug efflux
5-Fluorouracil (5-FU)
•Acquired resistance via insufficient activation
Mercaptopurine
• Acquired resistance via insufficient activation
Methotrexate
• Acquired resistance via:
-Decreased uptake of the drug
-Increased concentration of target enzyme
Antimetabolites
• Acquired resistance via utilization of alternative metabolic pathways
Alkylating agents
•Acquired resistance via increased repair of drug-induced lesions
Melanoma
•Inherited ( primary) resistance
#cologyiii_theory | 1 502 |
| 6 | +7 جمع وترتيب المعلومات بطريقة سهلة وبشكل جداول تلخص المادة.
يُعتمد عليها.
By 𝐀𝐡𝐮𝐫 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐬𝐭𝐮𝐝𝐞𝐧𝐭𝐬 | 1 666 |
| 7 |  Oral hypoglycemic drugs and their Safety - contraindications - caution features
#cologyiii_theory | 999 |
| 8 | ' Cancer chemotherapy '
Antimetabolites
Cell-cycle specific, active in the S-phase.
Bleomycin
Cell-cycle specific, active in the G₂-phase.
Vinca rosea derivatives
Cell-cycle specific, active in the M-phase.
Taxane derivatives
Cell-cycle specific, active in the G₂ / M-phase.
Platinum Coordination Complexes
Cell-cycle specific, active in the G₁ and S-phase.
Camptothecins
Cell-cycle specific, active in the S-phase.
Podophyllotoxins
Cell-cycle specific, active in the Late S to G₂-phase.
Proteosome Inhibitors
Cell-cycle specific
Anthracyclines
Cell-cycle non-specific.
Alkylating Agents
Cell-cycle non-specific.
Tyrosine Kinase Inhibitors
Cell-cycle non-specific.
#cologyiii_theory | 938 |
| 9 |  '' Contraceptives "
#cologyiii_theory | 809 |
| 10 | 🤔جميع الاسئلة الوزارية 👇👇
📝 اسئلة المصدر لكجر 1⃣2⃣3⃣
📝 30 سؤال لكجر 5⃣
📝 اسئلة المصدر لكجر 5⃣
📝الاسئلة الوزارية لكجر 5⃣
📝 اسئلة المصدر لكجر 6⃣
📝 الاسئلة الوزارية لكجر 6⃣
📝 25 سؤال لكجر 7⃣
📝 38 سؤال لكجر 8⃣ + 9⃣
📝 38 سؤال لجابتر ال Anti-cancer
📝 58 سؤال ل ٣ مواضيع مختلفة
📝 50 سؤال للكجر 1⃣2⃣3⃣
✅بوستات المراجعة 👇👇
✅بوست مراجعة لكجر 1⃣
✅بوست مراجعة لكجر 2⃣
✅مراجعة لاحد ادوية ال DMARDs
✅ملخص سريع DMARDs
✅بوست مراجعة لكجر 3⃣
✅الجزء الاول مراجعة لكجر 4⃣
✅الجزء الثاني مراجعة لكجر 4⃣
✅مراجعة لادوية لكجر 4⃣
✅ مراجعة لكل ادوية السكري 5⃣
✅الجزء الاول مراجعة لكجر 6⃣
✅الجزء الثاني مراجعة لكجر 6⃣
✅الجزء الثالث مراجعة لكجر 6⃣
✅مراجعة كل ال S.E لكجر 6⃣
✅مراجعة لكل ادوية لكجر 8⃣➕ 9⃣
✅تجميع كل ال Contraindications
📝ملخصات PDf 👇👇
🔗 ملخص ادوية الكانسر
🔗 ملخص جابتر ال DM
🔗ملخص سريع DMARDs
⭐️فقرات اخرى مهمة 👇👇
💡فقرة تذكر لكجر 3
💡 فقرة تذكر مهمة جدا
💡 فقرة تذكر لادوية الكانسر
1 MCQ lec7
2 MCQ lec 8
5 MCQ lec 1
By ⟹ 🧾 | 1 015 |
| 11 | DMARDs Dosing schedule
Adalimumab ⟹ Weekly or every other week
Certolizumab ⟹ every 2 weeks
Etanercept ⟹ Once weekly
Golimumab ⟹ once a month
Infliximab ⟹ every 8 weeks
Abatacept ⟹ every 4 weeks
Rituximab ⟹ every 16–24 w
Tocilizumab ⟹ every 2 weeks
Sarilumab
#cologyiii_theory | 997 |
| 12 | Mind maps for all chapters
• Anti-inflammatory
• Anti-inflammatory
• Biologic DMAR
• Disorders of the bone
• Pituitary and thyroid
• Diabetes mellitus
• Estrogen
• Progesterone
• Androgen
• Contraceptive
• Perfect summary for 'Cancer chemotherapy'
#cologyiii_theory | 1 088 |
| 13 | خطط علاج ال COPD
" 𝙁𝙤𝙧 𝙖𝙘𝙪𝙩𝙚 𝙚𝙭𝙖𝙘𝙚𝙧𝙗𝙖𝙩𝙞𝙤𝙣 "
Mild
SABA or SAMA only
Moderate
SABA or SAMA + Antibiotics (AB) and/or Oral Corticosteroids (OCS)
Severe
Hospitalization or emergency department (ED) visit
" 𝙈𝙖𝙞𝙣𝙩𝙚𝙣𝙖𝙣𝙘𝙚 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝙛𝙤𝙧 𝘿𝙮𝙨𝙥𝙣𝙚𝙖 "
LABA or LAMA (monotherapy)
first-line agents (prophylaxis).
👇🏻
LABA + LAMA (dual-therapy)
Patients with persistent breathlessness or exercise limitation on bronchodilator monotherapy.
👇🏻
Theophylline
Considered in patients intolerant of or unable to use inhaled bronchodilators [LABA + LAMA].
" 𝙈𝙖𝙞𝙣𝙩𝙚𝙣𝙖𝙣𝙘𝙚 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝙛𝙤𝙧 𝙀𝙭𝙖𝙘𝙚𝙧𝙗𝙖𝙩𝙞𝙤𝙣𝙨 "
LABA or LAMA (monotherapy)
first-line agents (prophylaxis)
👇🏻
LABA + LAMA (dual-therapy)
Patients with persistent exacerbations on monotherapy & if blood eosinophil < 300 cells/μL.
👇🏻
LABA + LAMA + ICS (triple-therapy)
Patients with persistent exacerbations on monotherapy & if blood eosinophil ≥ 300 cells/μL.
👇🏻
LABA + LAMA + ICS (triple-therapy)
Patients with persistent exacerbations on dual-therapy & if blood eosinophil ≥ 100 cells/μL.
👇🏻
Roflumilast or Azithromycin
Patients with persistent exacerbations on dual- or triple-therapy & if blood eosinophil < 100 cells/μL.
............
Roflumilast
Add-on therapy in patients with an FEV1 < 50% predicted and chronic bronchitis.
Azithromycin
Add-on therapy in patients who are not current smokers.
#clinicalii_theory | 1 546 |
| 14 | Which of the following considered as glycosuric (glucosuric) drug? | 1 169 |
| 15 |  #clinicalii_theory | 1 561 |
| 16 |  #clinicalii_theory | 1 331 |
| 17 |  #clinicalii_theory | 1 545 |
| 18 |  #clinicalii_theory | 1 497 |
| 19 | مبادرة من أحد زملائنا المجتهدين لشرح مادة السريرية خلال الفترة المتبقية ما قبل الامتحان
↧
Clinical pharmacy | 1 254 |
| 20 |  #clinicalii_theory | 1 624 |
